REDOX MEDECINE 2025

Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia

Christel MarquetteThe Redox Medicine Society is pleased to welcome Prof. Christel Marquette, from the Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France, to the 26th International Conference "Redox Medicine 2024" this June in Paris. 

Title: Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia

About Prof. Marquette
Christel Marquette is a Research Director at the French Alternative Energies and Atomic Energy Commission (CEA). Her recent research investigates the effects of prokineticins on cerebral cell function and blood-brain barrier permeability, contributing to the understanding of neurovascular interactions and potential therapeutic avenues for neurological disorders.

Redox Medicine 2024 Speaker Line-up.


Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn 

Scientific News

  • 1
  • 2
Prev Next


read all news